Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Barinthus Biotherapeutics (BRNS)
NASDAQ:BRNS
RESEARCH TOOLSreports
Barinthus Biotherapeutics (BRNS) Ownership - Who Owns Barinthus Biotherapeutics?
73 Followers
Barinthus Biotherapeutics (BRNS) Ownership Overview
39.62% Insiders
0.03% Mutual Funds
24.31% Other Institutional Investors
36.04% Public Companies and
Individual Investors
The ownership structure of Barinthus Biotherapeutics (BRNS) stock is a mix of institutional, retail and individual investors. Approximately 24.34% of the company’s stock is owned by Institutional Investors, 39.62% is owned by Insiders and 36.04% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jun 28, 2023 | Joseph Scheeren Director | Bought | $24400 |
| Jun 01, 2023 | Robin Wright Director | Bought | $36575 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 11,568 | Institution | 0.03% | 27,752 | |
| 124 | Institution | <0.01% | 297 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 11,568 | Institution | 0.03% | 27,752 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 124 | Institution | <0.01% | 293 |
FAQ
Who Owns Barinthus Biotherapeutics (BRNS)?
According to the latest TipRanks data, approximately 24.31% of the company's stock is held by institutional investors, 39.62% is held by insiders, and 36.04% is held by retail investors.
What percentage of Barinthus Biotherapeutics (BRNS) stock is held by institutional investors?
According to the latest TipRanks data, approximately 24.31% of Barinthus Biotherapeutics (BRNS) stock is held by institutional investors.
What percentage of Barinthus Biotherapeutics (BRNS) stock is held by retail investors?
According to the latest TipRanks data, approximately 36.04% of Barinthus Biotherapeutics (BRNS) stock is held by retail investors.
Who owns the most shares of Barinthus Biotherapeutics (BRNS)?
Fidelity Concord Street Trust owns the most shares of Barinthus Biotherapeutics (BRNS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.